Related Experiment Video
Updated: Feb 14, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
1.1K
Idiopathic pulmonary fibrosis: pathogenesis and management
Giacomo Sgalla1, Bruno Iovene2, Mariarosaria Calvello2
1Fondazione Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Unità Operativa Complessa di Pneumologia, Largo A. Gemelli, 8 -00168, Rome, Italy. giacomo.sgalla@gmail.com.
Respiratory Research
|February 24, 2018
Summary
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease. New antifibrotic drugs like nintedanib and pirfenidone slow IPF progression, but optimal use and personalized treatments are still under investigation.
Area of Science:
- Pulmonology
- Pathobiology
- Medical Therapeutics
Background:
- Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease causing lung scarring.
- Understanding IPF pathogenesis has advanced, identifying epithelial micro-injury as a key trigger in susceptible individuals.
- Diagnosis remains challenging, often requiring specific imaging or biopsy findings for classification.
Purpose of the Study:
- To review advances in IPF pathogenesis understanding.
- To discuss current and emerging therapeutic options for IPF.
- To address ongoing challenges in IPF diagnosis and management.
Main Methods:
- Review of recent scientific literature on IPF.
- Analysis of established and novel diagnostic criteria.
- Evaluation of current pharmacological treatments and ongoing research.
Main Results:
- Nintedanib and pirfenidone have demonstrated efficacy in slowing IPF progression.
- Optimal use, timing, and combination therapy of existing drugs require further clarification.
- Supportive care and comorbidity management are crucial aspects of IPF patient care.
Conclusions:
- Advances in understanding IPF pathobiology are paving the way for earlier diagnosis.
- Investigating gene variants, epigenetics, and biomarkers will support personalized IPF treatment.
- Further research is needed for improved disease phenotyping and novel therapeutic agents.
Keywords:
DiagnosisIdiopathic pulmonary fibrosisInterstitial lung diseaseManagementNintedanibPathogenesisPirfenidoneTreatmentMore Related Videos
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
896
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
896
01:30Pulmonary Hypertension: Classification and Pathogenesis
671
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
671
01:20Asthma: Pathogenesis and Management
1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
01:24Cystic Fibrosis: Management
549
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
549
01:27Pulmonary Embolism III: Nursing Management
458
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
458
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K